Skip to content

The effect of bupivacaine liposomes on the postoperative recovery quality of ankle surgery patients undergoing sciatic nerve and saphenous nerve block in the popliteal fossa: a single center double-blind randomized controlled trial clinical research protocol

The effect of bupivacaine liposomes on the postoperative recovery quality of ankle surgery patients undergoing sciatic nerve and saphenous nerve block in the popliteal fossa

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088305
Enrollment
Unknown
Registered
2024-08-15
Start date
2024-09-01
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankle surgery

Interventions

Ropivacaine nerve block anesthesia combined with general anesthesia group:After anesthesia induction intubation, ropivacaine was administered for sciatic nerve block and saphenous nerve block in the p
Bupivacaine liposome nerve block anesthesia combined with general anesthesia group:After the anesthesia induction and intubation, bupivacaine liposomes were administered for sciatic and saphenous nerv

Sponsors

Xuzhou Renci Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. BMI ranging from 18.5 to 35.0 kg/m^2; 2. Aged between 18 and 60 years; 3. ASA II-III classification; 4. Scheduled for ankle surgery under general anesthesia.

Exclusion criteria

Exclusion criteria: 1. Contraindications to general anesthesia, 2. Pregnancy status, 3. Inability to cooperate, 4. Participation in other drug trials, 5. Allergy to research drugs, 6. Use of opioids with an equivalent dose of morphine reaching or exceeding 30 mg per day, 7. Use of glucocorticoids with an equivalent dose of prednisone reaching or exceeding 5 mg per day, 8. Nervous system or musculoskeletal diseases, 9. Poor control of diabetes, 10. Contraindications to paracetamol or opioids, 11. Complications requiring surgery during the intervention period, and other traumatic injuries requiring management of opioids, 12. Local anesthetic allergy, infection at the puncture site, or abnormal coagulation function.

Design outcomes

Primary

MeasureTime frame
Duration of analgesia;

Secondary

MeasureTime frame
Duration of motor block;Postoperative Pittsburgh Sleep Quality Score;Postoperative QoR-40 score;Intraoperative medication dosage;

Countries

China

Contacts

Public ContactJian Zheng

Xuzhou Renci Hospital

18796217131@163.com+86 187 9621 7131

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026